Shopping News / Articles
How to submit | Gene therapy for cardiac and vascular disease
12+ hour ago (237+ words) Nature Thank you for visiting nature. com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet…...
AI can design and run thousands of lab experiments without human hands. Humanity isn't ready for the new risks this brings to biology
7+ hour, 12+ min ago (581+ words) Artificial intelligence (AI) is rapidly learning to autonomously design and run biological experiments, but the systems intended to govern those capabilities are struggling to keep pace. This is'programmable biology: designing biological components on a computer and building them in the…...
Key Players and Market Competition in the Cell Lysis and Disruption Industry
6+ hour, 15+ min ago (64+ words) open PR. com Key Players and Market Competition in the Cell Lysis and Disruption Industry Press release from: The Business Research Company Cell Lysis And Disruption Market Permanent link to this press release: You can edit or delete your press…...
Biomedical Crispr Gene Editing Market Set to Boom Rapidly, Witnessing Strong Growth Through 2033 | " CRISPR Therapeutics " Intellia Therapeutics " Caribou Biosciences
2+ hour, 58+ min ago (76+ words) Biomedical Crispr Gene Editing Market Set to Boom Rapidly, open PR. com Biomedical Crispr Gene Editing Market Set to Boom Rapidly, Witnessing Strong Growth Through 2033 | " CRISPR Therapeutics " Intellia Therapeutics " Caribou Biosciences Press release from: Coherent Market Insights Pvt. Ltd. Permanent…...
Future Prospects: Key Trends Shaping the Cellular Therapy Tracking Market Until 2030
6+ hour, 28+ min ago (52+ words) open PR. com We are establishing a secure connection. This website is using a security service to protect itself from online attacks. We are checking your browser to establish a secure connection and keep you safe. Performance & security by bunny....
From Delivery to Control: The Challenge of Ensuring Cell and Gene Therapy Designs Survive Reality at South Korea's 4th CGT Congress
4+ hour, 55+ min ago (848+ words) At the 4th Cell & Gene Therapy Innovation & Access Congress Asia, held in Seoul on April 910, 2026, discussions moved beyond questions of scientific feasibility toward a more consequential challenge: whether cell and gene therapies can withstand the realities of manufacturing, delivery, and clinical…...
Algenomics Partners with Surgynex on LNP-Based RNA Gene Therapy
11+ hour, 55+ min ago (181+ words) Seoul Economic Daily Algenomics (476830) announced on the 10th that it has signed a strategic memorandum of understanding (MOU) with Surgynex, a company specializing in lipid nanoparticle (LNP) delivery systems, for the development of LNP-based precision-guided next-generation RNA gene therapies. The two…...
Accelerating Time to Data in Cell and Gene Therapy Trials, Upcoming Webinar Hosted by Xtalks
1+ day, 1+ hour ago (175+ words) Apr 09, 2026, 08: 30 ET In this free webinar, gain insight into the factors impacting speed to data in CGT trials. The featured speakers will share key strategies and processes that can optimize study start-up activities and common operational bottlenecks to accelerate CGT…...
CGT Summit Seoul: South Korea's Cell and Gene Therapy Play Turns to Manufacturing, Access, and Real-World Delivery
5+ hour, 51+ min ago (844+ words) The Asia-Pacific cell and gene therapy (CGT) sector is entering a decisive phase of maturity'one defined less by scientific possibility and more by the ability to translate that science into durable, real-world systems. At the 4th CGT Innovation & Access Congress Asia…...
FDA Accepts Ultragenyx's New BLA Submission for MPS IIIA Gene Therapy UX111
7+ hour, 33+ min ago (175+ words) The new PDUFA action date for the BLA has been set at September 19, 2026. The FDA has accepted Ultragenyx's resubmission of a biologics license application (BLA) for UX111 (rebisufligene etisparvovec), an adeno-associated virus serotype 9 vector-based gene therapy intended to treat mucopolysaccharidosis type…...
Shopping
Please enter a search for detailed shopping results.